Video Experimental Relacionado
Updated: Jul 15, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Mirando hacia atrás para avanzar: detección temprana de trastornos neurodegenerativos
Steven T DeKosky1, Kenneth Marek
1Department of Neurology and Alzheimer Disease Research Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. DeKoskyST@upmc.edu
Science (New York, N.Y.)
|November 1, 2003
Resumen
La detección temprana de enfermedades neurodegenerativas como el Alzheimer y el Parkinson es posible gracias a las nuevas herramientas de la neurociencia molecular. Esto permite el diagnóstico presintomático y el desarrollo de tratamientos tempranos y modificadores de la enfermedad.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Diagnóstico médico Diagnóstico médico
- Patobiología Patobiología.
Sus antecedentes:
- Los trastornos neurodegenerativos, incluidos el Alzheimer y la enfermedad de Parkinson, son lentamente progresivos.
- La detección temprana es crucial para comprender los mecanismos de la enfermedad y mejorar los resultados de los pacientes.
- Las estrategias actuales de diagnóstico y tratamiento a menudo se inician después de que aparecen los síntomas clínicos.
Objetivo del estudio:
- Para resaltar el potencial de los avances recientes en la neurociencia molecular para la detección temprana de enfermedades neurodegenerativas.
- Hacer hincapié en los beneficios del diagnóstico presintomático para el tratamiento del paciente y el manejo de la enfermedad.
- Discutir el papel de las herramientas emergentes en la comprensión de la patobiología de la enfermedad.
Principales métodos:
- Utilizando marcadores genéticos para la predisposición a la enfermedad.
- Empleando técnicas avanzadas de neuroimagen para el análisis estructural y funcional.
- Aplicación de ensayos bioquímicos para identificar biomarcadores específicos de la enfermedad.
- Integrar las evaluaciones clínicas para la evaluación integral del paciente.
Principales resultados:
- Se están llevando a cabo estudios de validación para varias herramientas genéticas, de imágenes, clínicas y bioquímicas.
- Estas herramientas son prometedoras en la detección de enfermedades neurodegenerativas antes de las manifestaciones clínicas.
- Se está avanzando en la identificación de indicadores presintomáticos de la aparición de la enfermedad.
Conclusiones:
- La detección temprana de enfermedades neurodegenerativas es alcanzable a través de los avances de la neurociencia molecular.
- El diagnóstico pre-sintomático ofrece una ventana crítica para la intervención.
- El desarrollo de medicamentos modificadores de la enfermedad para uso precoz y presintomático es un objetivo futuro clave.
Videos de Conceptos Relacionados
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:13Amnesia
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...